TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapy.
about
Crosstalk of HNF4α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipidsImpairment of hepatic nuclear factor-4α binding to the Stim1 promoter contributes to high glucose-induced upregulation of STIM1 expression in glomerular mesangial cellsDiabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networksMolecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte.Signalling pathways involved in the process of mesenchymal stem cells differentiating into hepatocytes.Autophagy regulates hepatocyte identity and epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions promoting Snail degradationRegulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells.New Tools for Molecular Therapy of Hepatocellular Carcinoma.Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases.Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in RatsPARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma
P2860
Q28080239-E6B106AD-62B6-4979-8BA3-8B29095235C0Q35622475-8062B9C8-984F-403F-B6B5-789314146600Q37345580-C0ABE878-25B2-4E60-AB1F-FE9194D04632Q38177778-0B627D76-6213-421E-9010-F0CAE3CEBA6DQ38207092-69ED74BA-33B5-45A3-B2D0-8044494CEEB7Q38346070-3076DBBC-A73C-428D-BEBE-A0077F55E49BQ38836438-1297244A-6619-4B89-AB3A-AE5637251AA9Q40534248-C76F8761-03BE-4474-93F5-AA571C6FAF04Q40996773-025F80FB-BB7F-42E4-85A2-4F2ACB4FF3DFQ41889250-D5CEF6DB-4690-47B8-B8B2-A6DD27FD4D4DQ48146413-24E03898-6DBF-4F48-AAB1-443FC5DDCFF8Q52716832-E530402A-E38D-4449-A61C-A0C385AD9F9BQ57144042-2C30DCBE-EB10-4886-8A54-BDDCC13B2E52
P2860
TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
TGFβ overrides HNF4α tumor sup ...... llular carcinoma gene therapy.
@en
TGFβ overrides HNF4α tumor sup ...... llular carcinoma gene therapy.
@nl
type
label
TGFβ overrides HNF4α tumor sup ...... llular carcinoma gene therapy.
@en
TGFβ overrides HNF4α tumor sup ...... llular carcinoma gene therapy.
@nl
prefLabel
TGFβ overrides HNF4α tumor sup ...... llular carcinoma gene therapy.
@en
TGFβ overrides HNF4α tumor sup ...... llular carcinoma gene therapy.
@nl
P2093
P50
P1476
TGFβ overrides HNF4α tumor sup ...... ellular carcinoma gene therapy
@en
P2093
Beatrice Conti
Corinna Steindler
Laura Santangelo
Mariateresa Musone
Tonino Alonzi
P356
10.1016/J.JHEP.2012.08.023
P577
2012-09-04T00:00:00Z